New technology detects cancer before symptoms appear

Detecting lung cancer when there are no symptoms

"It was just a very small spot on the diagnostic scan, but AI "captured" that suspicious image. Thanks to the accurate image and professional experience, the doctor at NURA advised me to go to a specialized hospital for oncology. Both biopsies confirmed lung cancer. Although it is a serious disease, early detection helps make treatment more effective." That is the sharing of a female customer about the situation of detecting lung cancer very early, when she was screened at the NURA Hanoi High-Tech Screening Center.

AI system localizes and detects 10mm abnormalities in the lungs

According to experts, with early stage lung cancer (1A) like the case of the female patient mentioned above, the chance of cure is 90%. If the stage is later, even "a little" - stage 2A, the chance of cure is only 61%.

Another case is a 70-year-old patient NTN (Hanoi), with no medical history. She went for a routine check-up and NURA's AI system detected a 7mm lesion in her left breast, with a 97% risk of cancer. The subsequent biopsy results at the Oncology Hospital confirmed the lesion was malignant. Although the initial image showed the lesion was in the early stage (1A), the post-operative pathology results showed that it had progressed to stage 2, a rapidly progressing type. This case demonstrates the role of AI technology in supporting early detection of breast cancer, even when there are no clinical symptoms.

Detected 7mm nodular lesion in left breast

NURA experts say that more and more people are proactively checking their health and screening for serious diseases without waiting for signs of illness. Because proactive examination and screening detect common disease risk factors such as blood sugar, blood fat, overweight, etc., helping us to make timely adjustments and avoid the risk of cardiovascular diseases, stroke, high blood pressure or diabetes.

In particular, in the case of malignant diseases, screening at NURA helps detect them very early, providing the opportunity for a cure at a very low cost compared to the cost when the disease is in the late stages. Malignant diseases detected late also greatly affect the quality of life, even missing the opportunity for treatment.

"Previously, doctors were very careful when prescribing CT scans because there was always a risk factor affecting health from radiation, but if the radiation dose was reduced to the maximum, the image results were not guaranteed, making it difficult to diagnose. Therefore, with the AI ​​application at NURA, the X-ray dose is reduced to the maximum along with the ability to detect lesions from only a few mm and ensure safety, all customers can have CT scans of both the chest and abdomen to support doctors in screening for disease risks very early", said Dr. Hai Anh - Professional Director of Nura Vietnam, former Deputy Director of the Respiratory Center, Bach Mai Hospital.

Associate Professor, Dr. Nguyen Hai Anh - Professional Director of Nura Vietnam, former Deputy Director of Respiratory Center, Bach Mai Hospital

Exclusive technology from Japan detects early and accurately

Officially providing services in Hanoi since July 2024, NURA High-Tech Screening Center has applied AI (artificial intelligence) technology in cancer screening, with exclusive transfer from Fujifilm Japan.

Explaining the strength of the technology that helps diagnose very early and accurately, a NURA representative said that NURA uses Fujifilm's advanced medical equipment integrated with 50 exclusive AI software, along with doctors operating a standard screening flow with the most advanced medical equipment to support doctors in screening and testing for common cancers and lifestyle diseases.

Technology 50 exclusive AI software from Fujifilm Japan

At the same time, to ensure quality and accuracy in every touchpoint of the screening process, NURA Vietnam established a Professional Advisory Council, with the participation of leading experts, providing professional advice on technology application and medical standards in the field of cancer screening and lifestyle diseases.

This exclusive AI application from Fujifilm Japan has been certified by the US Food and Drug Administration (FDA) and deployed in many countries. This system allows for the localization and detection of lesions as small as 1mm, even at stage 0 - when the disease has not yet shown clinical symptoms.

Source: https://thanhnien.vn/cong-nghe-moi-phat-hien-ung-thu-khi-chua-co-trieu-chung-185250522100545871.htm